|
US5766573A
(en)
*
|
1988-12-06 |
1998-06-16 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
|
US5225183A
(en)
*
|
1988-12-06 |
1993-07-06 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
|
DE4003270A1
(de)
|
1990-02-03 |
1991-08-08 |
Boehringer Ingelheim Kg |
Neue treibgase und ihre verwendung in arzneimittelzubereitungen
|
|
AU650463B2
(en)
*
|
1990-06-27 |
1994-06-23 |
Minnesota Mining And Manufacturing Company |
The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
|
|
ATE114112T1
(de)
*
|
1990-10-18 |
1994-12-15 |
Minnesota Mining & Mfg |
Aerosolzubereitung, die beclometason 17,21- dipropionat enthält.
|
|
MX9203481A
(es)
|
1990-10-18 |
1992-07-01 |
Minnesota Mining & Mfg |
Formulaciones.
|
|
GB9024366D0
(en)
*
|
1990-11-09 |
1991-01-02 |
Glaxo Group Ltd |
Medicaments
|
|
HU205249B
(en)
*
|
1990-11-09 |
1992-04-28 |
Egyt Gyogyszervegyeszeti Gyar |
Process for producing suspensive aerosole composition
|
|
US5182040A
(en)
*
|
1991-03-28 |
1993-01-26 |
E. I. Du Pont De Nemours And Company |
Azeotropic and azeotrope-like compositions of 1,1,2,2-tetrafluoroethane
|
|
US5725791A
(en)
*
|
1991-03-28 |
1998-03-10 |
E. I. Du Pont De Nemours And Company |
Azeotropic and azeotrope-like compositions of 1,1,2,2-tetrafluoroethane
|
|
US6503482B1
(en)
|
1991-06-10 |
2003-01-07 |
Schering Corporation |
Non-chlorofluorocarbon aerosol formulations
|
|
PT656206E
(pt)
*
|
1991-06-10 |
2001-11-30 |
Schering Corp |
Formulacoes de aerossois sem clorofluorocarbonetos
|
|
DE4123663A1
(de)
*
|
1991-07-17 |
1993-01-21 |
Schwabe Willmar Gmbh & Co |
Aerosol-zubereitung und verwendung eines treibmittels dafuer
|
|
US5736124A
(en)
*
|
1991-12-12 |
1998-04-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicament
|
|
US5653962A
(en)
*
|
1991-12-12 |
1997-08-05 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
|
US5916540A
(en)
|
1994-10-24 |
1999-06-29 |
Glaxo Group Limited |
Aerosol formulations containing P134A and/or P227 and particulate medicament
|
|
IL104068A
(en)
†
|
1991-12-12 |
1998-10-30 |
Glaxo Group Ltd |
Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
|
|
NZ246046A
(en)
*
|
1991-12-12 |
1995-12-21 |
Glaxo Group Ltd |
Aerosol comprising a particulate medicament in a fluorocarbon or chlorofluorohydrocarbon and a polar cosolvent
|
|
US5674471A
(en)
*
|
1991-12-12 |
1997-10-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and salbutamol
|
|
JP3026841B2
(ja)
|
1991-12-12 |
2000-03-27 |
グラクソ、グループ、リミテッド |
医 薬
|
|
US5658549A
(en)
*
|
1991-12-12 |
1997-08-19 |
Glaxo Group Limited |
Aerosol formulations containing propellant 134a and fluticasone propionate
|
|
US5744123A
(en)
*
|
1991-12-12 |
1998-04-28 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
|
US20030103907A1
(en)
*
|
1991-12-18 |
2003-06-05 |
Schultz Robert K. |
Suspension aerosol formulations
|
|
US7101534B1
(en)
|
1991-12-18 |
2006-09-05 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
|
US7105152B1
(en)
|
1991-12-18 |
2006-09-12 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
|
DK0717987T3
(da)
*
|
1991-12-18 |
2001-11-12 |
Minnesota Mining & Mfg |
Suspension-aerosol-formuleringer
|
|
DE4203306A1
(de)
*
|
1992-02-06 |
1993-08-12 |
Ig Spruehtechnik Gmbh |
Asthma oder pulmonal-aerosolzubereitungen mit lecithin
|
|
DE4230876A1
(de)
|
1992-03-17 |
1993-09-23 |
Asta Medica Ag |
Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
|
|
AU4238393A
(en)
*
|
1992-05-04 |
1993-11-29 |
Minnesota Mining And Manufacturing Company |
Device for delivering an aerosol
|
|
DE4218291A1
(de)
*
|
1992-06-03 |
1993-12-09 |
Mattern Et Partner Pharmazeuti |
Dosierspray für pernasale Applikation
|
|
US5833950A
(en)
*
|
1992-07-31 |
1998-11-10 |
Glaxo Group Limited |
Aerosol formulations containing beclomethasone dipropionate-1, 1, 1, 2-tetrafluoroethane solvate
|
|
WO1994004629A1
(en)
*
|
1992-08-21 |
1994-03-03 |
E.I. Du Pont De Nemours And Company |
Substantially constant boiling mixtures of 1,1,1,2-tetrafluoroethane, dimethyl ether and isobutane
|
|
ES2129117T3
(es)
*
|
1992-12-09 |
1999-06-01 |
Boehringer Ingelheim Pharma |
Formulaciones en disolucion en forma de aerosol medicinales estabilizadas.
|
|
US5458798A
(en)
|
1993-02-05 |
1995-10-17 |
E. I. Du Pont De Nemours And Company |
Azeotropic and azeotrope-like compositions of a hydrofluorocarbon and a hydrocarbon
|
|
US5474758A
(en)
*
|
1993-07-28 |
1995-12-12 |
Minnesota Mining And Manufacturing Company |
Seals for use in an aerosol delivery device
|
|
EP0735884B1
(en)
*
|
1993-12-20 |
2000-04-26 |
Minnesota Mining And Manufacturing Company |
Flunisolide aerosol formulations
|
|
CH686806A5
(de)
*
|
1994-01-12 |
1996-06-28 |
Cerberus Ag |
Gasgemisch zur Funktionspruefung von Rauchmeldern.
|
|
US5417871A
(en)
*
|
1994-03-11 |
1995-05-23 |
E. I. Du Pont De Nemours And Company |
Hydrofluorocarbon compositions
|
|
US6001273A
(en)
|
1994-03-11 |
1999-12-14 |
Minor; Barbara Haviland |
Binary azeotropes of difluoromethane and hydrocarbons
|
|
GB9419536D0
(en)
*
|
1994-09-28 |
1994-11-16 |
Glaxo Inc |
Medicaments
|
|
US6524557B1
(en)
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
|
JP4155594B2
(ja)
*
|
1994-12-22 |
2008-09-24 |
アストラゼネカ・アクチエボラーグ |
エアゾール製剤
|
|
US6013245A
(en)
*
|
1995-01-26 |
2000-01-11 |
Glaxo Group Limited |
Aerosol formulation containing beclomethasone dipropionate and 1,1,1,2,3,3,3-heptafluoro-n-propane as propellant
|
|
GB9507768D0
(en)
|
1995-04-13 |
1995-05-31 |
Glaxo Group Ltd |
Method of apparatus
|
|
US6054488A
(en)
*
|
1996-06-11 |
2000-04-25 |
3M Innovative Properties Company |
Medicinal aerosol formulations of formoterol
|
|
GB9616237D0
(en)
|
1996-08-01 |
1996-09-11 |
Norton Healthcare Ltd |
Aerosol formulations
|
|
US6039932A
(en)
*
|
1996-09-27 |
2000-03-21 |
3M Innovative Properties Company |
Medicinal inhalation aerosol formulations containing budesonide
|
|
GB9620187D0
(en)
*
|
1996-09-27 |
1996-11-13 |
Minnesota Mining & Mfg |
Medicinal aerosol formulations
|
|
US6461591B1
(en)
|
1997-02-05 |
2002-10-08 |
Jago Research Ag |
Medical aerosol formulations
|
|
US6120752A
(en)
*
|
1997-05-21 |
2000-09-19 |
3M Innovative Properties Company |
Medicinal aerosol products containing formulations of ciclesonide and related steroids
|
|
US6086376A
(en)
*
|
1998-01-30 |
2000-07-11 |
Rtp Pharma Inc. |
Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
|
|
GB9805938D0
(en)
|
1998-03-19 |
1998-05-13 |
Glaxo Group Ltd |
Valve for aerosol container
|
|
US6264923B1
(en)
|
1998-05-13 |
2001-07-24 |
3M Innovative Properties Company |
Medicinal aerosol formulation of ciclesonide and related compounds
|
|
US6423298B2
(en)
*
|
1998-06-18 |
2002-07-23 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Pharmaceutical formulations for aerosols with two or more active substances
|
|
NZ509328A
(en)
|
1998-07-24 |
2002-11-26 |
Jago Res A |
Medicinal aerosol formulations
|
|
ATE234604T1
(de)
|
1998-08-04 |
2003-04-15 |
Jago Res Ag |
Medizinische aerosolformulierungen
|
|
US6458338B1
(en)
*
|
1998-09-22 |
2002-10-01 |
Aeropharm Technology Incorporated |
Amino acid stabilized medicinal aerosol formulations
|
|
PL352615A1
(en)
|
1999-06-05 |
2003-08-25 |
Innovata Biomed Ltd |
Delivery system
|
|
GB9920839D0
(en)
|
1999-09-04 |
1999-11-10 |
Innovata Biomed Ltd |
Inhaler
|
|
JP2004509159A
(ja)
|
2000-09-22 |
2004-03-25 |
グラクソ グループ リミテッド |
新規なアルカン酸誘導体
|
|
US20020193392A1
(en)
*
|
2000-11-13 |
2002-12-19 |
Christel Schmelzer |
Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
|
|
NZ526564A
(en)
|
2000-12-22 |
2004-12-24 |
Glaxo Group Ltd |
Metered dose inhaler for salmeterol xinafoate
|
|
US20110301569A1
(en)
|
2001-01-20 |
2011-12-08 |
Gordon Wayne Dyer |
Methods and apparatus for the CVCS
|
|
US20030018019A1
(en)
*
|
2001-06-23 |
2003-01-23 |
Boehringer Ingelheim Pharma Kg |
Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
|
|
GB0208742D0
(en)
|
2002-04-17 |
2002-05-29 |
Bradford Particle Design Ltd |
Particulate materials
|
|
US6919325B2
(en)
|
2001-09-14 |
2005-07-19 |
Boehringer Ingelheim Pharma Kg |
Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
|
|
GB0128148D0
(en)
|
2001-11-23 |
2002-01-16 |
Innovata Biomed Ltd |
Assembly
|
|
JP2005517701A
(ja)
|
2002-02-13 |
2005-06-16 |
グラクソ グループ リミテッド |
界面活性剤として使用するためのカルボン酸化合物
|
|
GB0205327D0
(en)
|
2002-03-06 |
2002-04-17 |
Glaxo Group Ltd |
compounds
|
|
US7754242B2
(en)
*
|
2002-03-20 |
2010-07-13 |
Alkermes, Inc. |
Inhalable sustained therapeutic formulations
|
|
US7582284B2
(en)
|
2002-04-17 |
2009-09-01 |
Nektar Therapeutics |
Particulate materials
|
|
US7279451B2
(en)
*
|
2002-10-25 |
2007-10-09 |
Honeywell International Inc. |
Compositions containing fluorine substituted olefins
|
|
US20040152720A1
(en)
*
|
2002-12-20 |
2004-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
|
|
AU2004246819A1
(en)
|
2003-06-13 |
2004-12-23 |
Nycomed Gmbh |
Formoterol and ciclesonide combination
|
|
JP4607112B2
(ja)
|
2003-08-11 |
2011-01-05 |
グラクソ グループ リミテッド |
医薬定量噴霧式吸入器及び前記吸引器に関連する方法
|
|
AU2004270171A1
(en)
|
2003-08-29 |
2005-03-17 |
Glaxo Group Limited |
Pharmaceutical metered dose inhaler and methods relating thereto
|
|
WO2005025578A1
(en)
|
2003-09-16 |
2005-03-24 |
Altana Pharma Ag |
Use of ciclesonide for the treatment of respiratory diseases
|
|
AR041873A1
(es)
*
|
2003-10-30 |
2005-06-01 |
Pablo Cassara Srl Lab |
Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
|
|
WO2005102429A1
(en)
|
2004-04-21 |
2005-11-03 |
Innovata Biomed Limited |
Inhaler
|
|
PL2425820T3
(pl)
|
2007-02-11 |
2015-08-31 |
Map Pharmaceuticals Inc |
Sposób terapeutycznego stosowania dhe w celu umożliwienia szybkiego złagodzenia migreny przy jednoczesnym zminimalizowaniu profilu działań niepożądanych
|
|
JP2012514586A
(ja)
|
2009-01-05 |
2012-06-28 |
フラウンホーファーゲゼルシャフト ツール フォルデルング デル アンゲヴァンテン フォルシユング エー.フアー. |
Il−21およびil−21変異体に基づく抗体欠乏性疾患を治療するための手段および方法
|
|
AU2010324997A1
(en)
|
2009-11-24 |
2012-05-31 |
Gilead Sciences, Inc. |
Inhaled fosfomycin/tobramycin for the treatment of chronic obstructive pulmonary disease
|
|
WO2011081937A1
(en)
|
2009-12-15 |
2011-07-07 |
Gilead Sciences, Inc. |
Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy
|
|
AR079451A1
(es)
|
2009-12-18 |
2012-01-25 |
Nycomed Gmbh |
Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
|
|
US8394829B2
(en)
|
2010-05-10 |
2013-03-12 |
Gilead Sciences, Inc. |
Bi-functional quinoline analogs
|
|
WO2011143106A1
(en)
|
2010-05-10 |
2011-11-17 |
Gilead Sciences, Inc. |
Bi - functional pyrazolopyridine compounds
|
|
EP2575864A1
(en)
|
2010-06-04 |
2013-04-10 |
Trifoilium ApS |
Trefoil factors (tff) for the treatment of chronic pulmonary diseases
|
|
CN103221039A
(zh)
|
2010-09-09 |
2013-07-24 |
三叶草私人有限公司 |
血管生成抑制剂的气道给药
|
|
GB201108039D0
(en)
|
2011-05-13 |
2011-06-29 |
Mexichem Amanco Holding Sa |
Compositions
|
|
JP2014519519A
(ja)
|
2011-06-15 |
2014-08-14 |
タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規3,4,4a,10b−テトラヒドロ−1H−チオピラノ[4,3−c]イソキノリン化合物
|
|
MX2013014888A
(es)
|
2011-06-17 |
2014-02-27 |
Takeda Gmbh |
Novedosos derivados de ftalazinona-pirrolopirimidinacarboxamida.
|
|
AR086745A1
(es)
|
2011-06-27 |
2014-01-22 |
Parion Sciences Inc |
3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
|
|
GB201117619D0
(en)
|
2011-10-12 |
2011-11-23 |
Mexichem Amanco Holding Sa |
Compositions
|
|
GB201117621D0
(en)
|
2011-10-12 |
2011-11-23 |
Mexichem Amanco Holding Sa |
Compositions
|
|
WO2013181232A2
(en)
|
2012-05-29 |
2013-12-05 |
Michael Ross Johnson |
Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
|
|
ES2674665T3
(es)
|
2012-12-17 |
2018-07-03 |
Parion Sciences, Inc. |
Compuestos de 3,5-diamino-6-cloro-N-(N-(4-fenilbutilo)carbamimidoilo)-pirazina-2-carboxamida
|
|
HUE032891T2
(hu)
|
2012-12-17 |
2017-11-28 |
Parion Sciences Inc |
Klórpirazin-karboxamid-származékok nem kielégítõ nyálkahártya-hidratáció által elõsegített megbetegedések kezelésére
|
|
RU2671976C2
(ru)
|
2012-12-17 |
2018-11-08 |
Пэрион Сайенсиз, Инк. |
Соединения 3,5-диамино-6-хлор-n-(n-(4-фенилбутил)карбамимидоил)пиразин-2-карбоксамида
|
|
GB201306984D0
(en)
*
|
2013-04-17 |
2013-05-29 |
Mexichem Amanco Holding Sa |
Composition
|
|
CN112472689B
(zh)
|
2015-12-04 |
2023-01-17 |
墨西哥氟石股份公司 |
药物组合物
|
|
EP3515425B1
(en)
|
2016-09-19 |
2021-06-09 |
Mexichem Fluor S.A. de C.V. |
Pharmaceutical composition comprising salmeterol
|
|
CN113288869A
(zh)
|
2016-09-19 |
2021-08-24 |
墨西哥氟石股份公司 |
药物组合物
|
|
JP6781829B2
(ja)
|
2016-09-19 |
2020-11-04 |
メキシケム フロー エセ・ア・デ・セ・ヴェ |
医薬組成物
|
|
WO2018069210A1
(en)
|
2016-10-10 |
2018-04-19 |
Takeda Gmbh |
Tetrahydrofuro[3,4-c]isoquinolines as inhibitors of pde4
|